Cao Longxiang & family

CEO, Hubei Jumpcan Pharmaceutical

Real-Time Net Worth

$2.9B

As of December 2025

Age

Source

Pharmaceuticals

Industry

healthcare

Citizenship

Biography

Cao Longxiang, at 68 years old, is the chairman of Hubei Jumpcan Pharmaceutical, one of China's largest pharmaceutical companies, specializing in both Western and traditional Chinese medicine. His source of wealth is pharmaceuticals, a sector where he has built a successful career. Cao's career began after serving in the Chinese military and working as a manager at a cement factory before entering the pharma business. As of December 4, 2025, his real-time net worth is estimated at $2.9 Billion.

Wealth Over Time

Portfolio Holdings

Hubei Jumpcan Pharmaceutical

In-Depth Profile

Early Life

Cao Longxiang began his career outside of the pharmaceutical industry, working as a manager at a cement factory. Before that, he served in the Chinese military.

Rise to Success

Cao Longxiang chairs Hubei Jumpcan Pharmaceutical, one of China's largest drug companies. The company went public in 2001 as Hubei Hongcheng General Machinery, before Cao took control in 2013; he now owns more than 60% of the company. Cao's son, Cao Fei, serves as the company's vice chairman.

Key Business Strategies

Cao Longxiang's primary focus has been leading Hubei Jumpcan Pharmaceutical, concentrating on both Western and traditional Chinese medicine. Under his leadership, the company has grown to become a major player in the Chinese pharmaceutical market.

Philanthropy

Information regarding Cao Longxiang's specific philanthropic initiatives and amounts could not be found via search.

Career Milestones

2001

Hubei Hongcheng General Machinery

The company went public.

2013

Took control of Hubei Jumpcan Pharmaceutical

Cao took control of the company and now owns more than 60%.